Virtu Financial’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Other funds holding ZNTL
Virtu Financial's ZNTL Position: Q3 2026 in Review
Virtu Financial opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q3 2026: 16,752 shares worth $46K. The stake represents ﹤0.01% of the portfolio and ranks #1263 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ZNTL as recently as Q4 2024.
Virtu Financial first reported a position in ZNTL in Q4 2020 and has held it in 5 quarters since. The position peaked at $381K in Q2 2024. 128 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.
- Virtu Financial held 16,752 shares of Zentalis Pharmaceuticals worth $46K as of Q3 2026.
- Zentalis Pharmaceuticals was a new Virtu Financial position in Q3 2026.
- Zentalis Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q3 2026, its #1263 holding.
- Virtu Financial first reported a position in Zentalis Pharmaceuticals in Q4 2020 and has held it in 5 quarters since.
- Virtu Financial's Zentalis Pharmaceuticals position peaked at $381K in Q2 2024.
- 128 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.
Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.